 | • レポートコード：QYR9ST02915 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界の炎症性腸疾患薬市場について調査・分析し、以下の構成でお届け致します。炎症性腸疾患薬の種類別には、潰瘍性大腸炎、クローン病、不確定性大腸炎、その他に、用途別には、アミノサリチル酸塩、抗生物質、コルチコステロイド、免疫調節薬、生物製剤、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別炎症性腸疾患薬売上データ ・地域別炎症性腸疾患薬市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別炎症性腸疾患薬市場規模：潰瘍性大腸炎、クローン病、不確定性大腸炎、その他 ・用途別炎症性腸疾患薬市場規模：アミノサリチル酸塩、抗生物質、コルチコステロイド、免疫調節薬、生物製剤、その他 ・主要メーカーの企業情報：Abbott Laboratories、Biocon Ltd、Roche、Johnson and Johnson、Mylan Pharmaceuticals、Novartis AG、Pfizer、Quest Medical、Sanofi、Takeda Pharmaceutical ・炎症性腸疾患薬の市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
Inflammatory bowel disease is a condition generally caused when immune system attacks harmless bacteria, virus, or food in the intestine. The most common inflammatory bowel diseases are ulcerative colitis and Crohns disease. The growth in prevalence of inflammatory bowel diseases such as ulcerative colitis and Crohn’s disease majorly drives the growth of the market. In addition, increase in intake of unhealthy food and drinks, and sedentary and stressful lifestyle propels the growth of the market. The increase in healthcare expenditure by government and private organizations is anticipated to increase the market growth.
The global Inflammatory Bowel Disease Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Inflammatory Bowel Disease Drugs market based on company, product type, end user and key regions.
This report studies the global market size of Inflammatory Bowel Disease Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Inflammatory Bowel Disease Drugs in these regions.
This research report categorizes the global Inflammatory Bowel Disease Drugs market by top players/brands, region, type and end user. This report also studies the global Inflammatory Bowel Disease Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Abbott Laboratories
Biocon Ltd
Roche
Johnson and Johnson
Mylan Pharmaceuticals
Novartis AG
Pfizer
Quest Medical
Sanofi
Takeda Pharmaceutical
Market size by Product
Ulcerative Colitis
Crohns Disease
Indeterminate Colitis
Others
Market size by End User
Amino-salicylates
Antibiotics
Corticosteroids
Immunomodulators
Biologics
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Inflammatory Bowel Disease Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Inflammatory Bowel Disease Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Inflammatory Bowel Disease Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Inflammatory Bowel Disease Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Inflammatory Bowel Disease Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Inflammatory Bowel Disease Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Inflammatory Bowel Disease Drugs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Inflammatory Bowel Disease Drugs Market Size Growth Rate by Product
1.4.2 Ulcerative Colitis
1.4.3 Crohns Disease
1.4.4 Indeterminate Colitis
1.4.5 Others
1.5 Market by End User
1.5.1 Global Inflammatory Bowel Disease Drugs Market Size Growth Rate by End User
1.5.2 Amino-salicylates
1.5.3 Antibiotics
1.5.4 Corticosteroids
1.5.5 Immunomodulators
1.5.6 Biologics
1.5.7 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Inflammatory Bowel Disease Drugs Market Size
2.1.1 Global Inflammatory Bowel Disease Drugs Revenue 2014-2025
2.1.2 Global Inflammatory Bowel Disease Drugs Sales 2014-2025
2.2 Inflammatory Bowel Disease Drugs Growth Rate by Regions
2.2.1 Global Inflammatory Bowel Disease Drugs Sales by Regions
2.2.2 Global Inflammatory Bowel Disease Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Inflammatory Bowel Disease Drugs Sales by Manufacturers
3.1.1 Inflammatory Bowel Disease Drugs Sales by Manufacturers
3.1.2 Inflammatory Bowel Disease Drugs Sales Market Share by Manufacturers
3.1.3 Global Inflammatory Bowel Disease Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Inflammatory Bowel Disease Drugs Revenue by Manufacturers
3.2.1 Inflammatory Bowel Disease Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Inflammatory Bowel Disease Drugs Revenue Share by Manufacturers (2014-2019)
3.3 Inflammatory Bowel Disease Drugs Price by Manufacturers
3.4 Inflammatory Bowel Disease Drugs Manufacturing Base Distribution, Product Types
3.4.1 Inflammatory Bowel Disease Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Inflammatory Bowel Disease Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Inflammatory Bowel Disease Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Inflammatory Bowel Disease Drugs Sales by Product
4.2 Global Inflammatory Bowel Disease Drugs Revenue by Product
4.3 Inflammatory Bowel Disease Drugs Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Inflammatory Bowel Disease Drugs Breakdown Data by End User
6 North America
6.1 North America Inflammatory Bowel Disease Drugs by Countries
6.1.1 North America Inflammatory Bowel Disease Drugs Sales by Countries
6.1.2 North America Inflammatory Bowel Disease Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Inflammatory Bowel Disease Drugs by Product
6.3 North America Inflammatory Bowel Disease Drugs by End User
7 Europe
7.1 Europe Inflammatory Bowel Disease Drugs by Countries
7.1.1 Europe Inflammatory Bowel Disease Drugs Sales by Countries
7.1.2 Europe Inflammatory Bowel Disease Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Inflammatory Bowel Disease Drugs by Product
7.3 Europe Inflammatory Bowel Disease Drugs by End User
8 Asia Pacific
8.1 Asia Pacific Inflammatory Bowel Disease Drugs by Countries
8.1.1 Asia Pacific Inflammatory Bowel Disease Drugs Sales by Countries
8.1.2 Asia Pacific Inflammatory Bowel Disease Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Inflammatory Bowel Disease Drugs by Product
8.3 Asia Pacific Inflammatory Bowel Disease Drugs by End User
9 Central & South America
9.1 Central & South America Inflammatory Bowel Disease Drugs by Countries
9.1.1 Central & South America Inflammatory Bowel Disease Drugs Sales by Countries
9.1.2 Central & South America Inflammatory Bowel Disease Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Inflammatory Bowel Disease Drugs by Product
9.3 Central & South America Inflammatory Bowel Disease Drugs by End User
10 Middle East and Africa
10.1 Middle East and Africa Inflammatory Bowel Disease Drugs by Countries
10.1.1 Middle East and Africa Inflammatory Bowel Disease Drugs Sales by Countries
10.1.2 Middle East and Africa Inflammatory Bowel Disease Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Inflammatory Bowel Disease Drugs by Product
10.3 Middle East and Africa Inflammatory Bowel Disease Drugs by End User
11 Company Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Company Business Overview
11.1.3 Abbott Laboratories Inflammatory Bowel Disease Drugs Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Abbott Laboratories Inflammatory Bowel Disease Drugs Products Offered
11.1.5 Abbott Laboratories Recent Development
11.2 Biocon Ltd
11.2.1 Biocon Ltd Company Details
11.2.2 Company Business Overview
11.2.3 Biocon Ltd Inflammatory Bowel Disease Drugs Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Biocon Ltd Inflammatory Bowel Disease Drugs Products Offered
11.2.5 Biocon Ltd Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Company Business Overview
11.3.3 Roche Inflammatory Bowel Disease Drugs Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Roche Inflammatory Bowel Disease Drugs Products Offered
11.3.5 Roche Recent Development
11.4 Johnson and Johnson
11.4.1 Johnson and Johnson Company Details
11.4.2 Company Business Overview
11.4.3 Johnson and Johnson Inflammatory Bowel Disease Drugs Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Johnson and Johnson Inflammatory Bowel Disease Drugs Products Offered
11.4.5 Johnson and Johnson Recent Development
11.5 Mylan Pharmaceuticals
11.5.1 Mylan Pharmaceuticals Company Details
11.5.2 Company Business Overview
11.5.3 Mylan Pharmaceuticals Inflammatory Bowel Disease Drugs Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Mylan Pharmaceuticals Inflammatory Bowel Disease Drugs Products Offered
11.5.5 Mylan Pharmaceuticals Recent Development
11.6 Novartis AG
11.6.1 Novartis AG Company Details
11.6.2 Company Business Overview
11.6.3 Novartis AG Inflammatory Bowel Disease Drugs Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Novartis AG Inflammatory Bowel Disease Drugs Products Offered
11.6.5 Novartis AG Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Company Business Overview
11.7.3 Pfizer Inflammatory Bowel Disease Drugs Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Pfizer Inflammatory Bowel Disease Drugs Products Offered
11.7.5 Pfizer Recent Development
11.8 Quest Medical
11.8.1 Quest Medical Company Details
11.8.2 Company Business Overview
11.8.3 Quest Medical Inflammatory Bowel Disease Drugs Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Quest Medical Inflammatory Bowel Disease Drugs Products Offered
11.8.5 Quest Medical Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Company Business Overview
11.9.3 Sanofi Inflammatory Bowel Disease Drugs Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Sanofi Inflammatory Bowel Disease Drugs Products Offered
11.9.5 Sanofi Recent Development
11.10 Takeda Pharmaceutical
11.10.1 Takeda Pharmaceutical Company Details
11.10.2 Company Business Overview
11.10.3 Takeda Pharmaceutical Inflammatory Bowel Disease Drugs Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Takeda Pharmaceutical Inflammatory Bowel Disease Drugs Products Offered
11.10.5 Takeda Pharmaceutical Recent Development
12 Future Forecast
12.1 Inflammatory Bowel Disease Drugs Market Forecast by Regions
12.1.1 Global Inflammatory Bowel Disease Drugs Sales Forecast by Regions 2019-2025
12.1.2 Global Inflammatory Bowel Disease Drugs Revenue Forecast by Regions 2019-2025
12.2 Inflammatory Bowel Disease Drugs Market Forecast by Product
12.2.1 Global Inflammatory Bowel Disease Drugs Sales Forecast by Product 2019-2025
12.2.2 Global Inflammatory Bowel Disease Drugs Revenue Forecast by Product 2019-2025
12.3 Inflammatory Bowel Disease Drugs Market Forecast by End User
12.4 North America Inflammatory Bowel Disease Drugs Forecast
12.5 Europe Inflammatory Bowel Disease Drugs Forecast
12.6 Asia Pacific Inflammatory Bowel Disease Drugs Forecast
12.7 Central & South America Inflammatory Bowel Disease Drugs Forecast
12.8 Middle East and Africa Inflammatory Bowel Disease Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Inflammatory Bowel Disease Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Inflammatory Bowel Disease Drugs Product Picture
Table Inflammatory Bowel Disease Drugs Market Segments
Table Key Manufacturers Inflammatory Bowel Disease Drugs Covered
Table Global Inflammatory Bowel Disease Drugs Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Inflammatory Bowel Disease Drugs Sales Market Share by Product 2014-2025
Figure Ulcerative Colitis Product Picture
Table Major Manufacturers of Ulcerative Colitis
Figure Crohns Disease Product Picture
Table Major Manufacturers of Crohns Disease
Figure Indeterminate Colitis Product Picture
Table Major Manufacturers of Indeterminate Colitis
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Inflammatory Bowel Disease Drugs Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Amino-salicylates
Figure Antibiotics
Figure Corticosteroids
Figure Immunomodulators
Figure Biologics
Figure Others
Figure Inflammatory Bowel Disease Drugs Report Years Considered
Figure Global Inflammatory Bowel Disease Drugs Market Size 2014-2025 (Million US$)
Figure Global Inflammatory Bowel Disease Drugs Sales 2014-2025 (K Units)
Table Global Inflammatory Bowel Disease Drugs Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Inflammatory Bowel Disease Drugs Sales by Regions 2014-2019 (K Units)
Table Global Inflammatory Bowel Disease Drugs Sales Market Share by Regions 2014-2019
Figure Global Inflammatory Bowel Disease Drugs Sales Market Share by Regions 2014-2019
Figure 2018 Global Inflammatory Bowel Disease Drugs Sales Market Share by Regions
Table Global Inflammatory Bowel Disease Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Inflammatory Bowel Disease Drugs Revenue Market Share by Regions 2014-2019
Figure Global Inflammatory Bowel Disease Drugs Revenue Market Share by Regions 2014-2019
Figure 2018 Global Inflammatory Bowel Disease Drugs Revenue Market Share by Regions
Table Global Inflammatory Bowel Disease Drugs Sales by Manufacturers (2014-2019) (K Units)
Table Global Inflammatory Bowel Disease Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Inflammatory Bowel Disease Drugs Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Inflammatory Bowel Disease Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Inflammatory Bowel Disease Drugs Revenue Share by Manufacturers (2014-2019)
Figure Inflammatory Bowel Disease Drugs Value Share by Manufacturers in 2018
Table Key Manufacturers Inflammatory Bowel Disease Drugs Price (2014-2019) (USD/Unit)
Table Inflammatory Bowel Disease Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Inflammatory Bowel Disease Drugs Product Type
Table Date of International Manufacturers Enter into Inflammatory Bowel Disease Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Inflammatory Bowel Disease Drugs Sales by Product (2014-2019) (K Units)
Table Global Inflammatory Bowel Disease Drugs Sales Share by Product (2014-2019)
Figure Global Inflammatory Bowel Disease Drugs Sales Market Share by Product (2014-2019)
Figure Global Inflammatory Bowel Disease Drugs Sales Market Share by Product in 2018
Table Global Inflammatory Bowel Disease Drugs Revenue by Product (2014-2019) (Million US$)
Table Global Inflammatory Bowel Disease Drugs Revenue Share by Product (2014-2019)
Figure Global Inflammatory Bowel Disease Drugs Revenue Market Share by Product (2014-2019)
Figure Global Inflammatory Bowel Disease Drugs Revenue Market Share by Product in 2018
Table Inflammatory Bowel Disease Drugs Price by Product 2014-2019 (USD/Unit)
Table Global Inflammatory Bowel Disease Drugs Sales by End User (2014-2019) (K Units)
Table Global Inflammatory Bowel Disease Drugs Sales Share by End User (2014-2019)
Figure Global Sales Inflammatory Bowel Disease Drugs Market Share by End User (2014-2019)
Figure Global Sales Inflammatory Bowel Disease Drugs Market Share by End User in 2018
Figure North America Inflammatory Bowel Disease Drugs Sales Growth Rate 2014-2019 (K Units)
Figure North America Inflammatory Bowel Disease Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table North America Inflammatory Bowel Disease Drugs Sales by Countries (2014-2019) (K Units)
Table North America Inflammatory Bowel Disease Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 North America Inflammatory Bowel Disease Drugs Sales Market Share by Countries
Table North America Inflammatory Bowel Disease Drugs Revenue by Countries (2014-2019) (Million US$)
Table North America Inflammatory Bowel Disease Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Inflammatory Bowel Disease Drugs Revenue Market Share by Countries
Figure United States Inflammatory Bowel Disease Drugs Sales Growth Rate (2014-2019) (K Units)
Figure United States Inflammatory Bowel Disease Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Inflammatory Bowel Disease Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Canada Inflammatory Bowel Disease Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Inflammatory Bowel Disease Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Inflammatory Bowel Disease Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table North America Inflammatory Bowel Disease Drugs Sales by Product (2014-2019) (K Units)
Table North America Inflammatory Bowel Disease Drugs Sales Market Share by Product (2014-2019)
Figure 2018 North America Inflammatory Bowel Disease Drugs Market Share by Product
Table North America Inflammatory Bowel Disease Drugs Sales by End User (2014-2019) (K Units)
Table North America Inflammatory Bowel Disease Drugs Sales Market Share by End User (2014-2019)
Figure 2018 North America Inflammatory Bowel Disease Drugs Market Share by End User
Figure Europe Inflammatory Bowel Disease Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Europe Inflammatory Bowel Disease Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Inflammatory Bowel Disease Drugs Sales by Countries (2014-2019) (K Units)
Table Europe Inflammatory Bowel Disease Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Inflammatory Bowel Disease Drugs Sales Market Share by Countries
Table Europe Inflammatory Bowel Disease Drugs Revenue by Countries (2014-2019) (Million US$)
Table Europe Inflammatory Bowel Disease Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Inflammatory Bowel Disease Drugs Revenue Market Share by Countries
Figure Germany Inflammatory Bowel Disease Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Germany Inflammatory Bowel Disease Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure France Inflammatory Bowel Disease Drugs Sales Growth Rate (2014-2019) (K Units)
Figure France Inflammatory Bowel Disease Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Inflammatory Bowel Disease Drugs Sales Growth Rate (2014-2019) (K Units)
Figure UK Inflammatory Bowel Disease Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Inflammatory Bowel Disease Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Italy Inflammatory Bowel Disease Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Inflammatory Bowel Disease Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Russia Inflammatory Bowel Disease Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Inflammatory Bowel Disease Drugs Sales by Product (2014-2019) (K Units)
Table Europe Inflammatory Bowel Disease Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Europe Inflammatory Bowel Disease Drugs Market Share by Product
Table Europe Inflammatory Bowel Disease Drugs Sales by End User (2014-2019) (K Units)
Table Europe Inflammatory Bowel Disease Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Europe Inflammatory Bowel Disease Drugs Market Share by End User
Figure Asia Pacific Inflammatory Bowel Disease Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Inflammatory Bowel Disease Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Inflammatory Bowel Disease Drugs Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Inflammatory Bowel Disease Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Inflammatory Bowel Disease Drugs Sales Market Share by Countries
Table Asia Pacific Inflammatory Bowel Disease Drugs Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Inflammatory Bowel Disease Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Inflammatory Bowel Disease Drugs Revenue Market Share by Countries
Figure China Inflammatory Bowel Disease Drugs Sales Growth Rate (2014-2019) (K Units)
Figure China Inflammatory Bowel Disease Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Inflammatory Bowel Disease Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Japan Inflammatory Bowel Disease Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Inflammatory Bowel Disease Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Korea Inflammatory Bowel Disease Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure India Inflammatory Bowel Disease Drugs Sales Growth Rate (2014-2019) (K Units)
Figure India Inflammatory Bowel Disease Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Inflammatory Bowel Disease Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Australia Inflammatory Bowel Disease Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Inflammatory Bowel Disease Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Inflammatory Bowel Disease Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Inflammatory Bowel Disease Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Inflammatory Bowel Disease Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Inflammatory Bowel Disease Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Inflammatory Bowel Disease Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Inflammatory Bowel Disease Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Inflammatory Bowel Disease Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Inflammatory Bowel Disease Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Inflammatory Bowel Disease Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Inflammatory Bowel Disease Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Inflammatory Bowel Disease Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Inflammatory Bowel Disease Drugs Sales by Product (2014-2019) (K Units)
Table Asia Pacific Inflammatory Bowel Disease Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Inflammatory Bowel Disease Drugs Market Share by Product
Table Asia Pacific Inflammatory Bowel Disease Drugs Sales by End User (2014-2019) (K Units)
Table Asia Pacific Inflammatory Bowel Disease Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Inflammatory Bowel Disease Drugs Market Share by End User
Figure Central & South America Inflammatory Bowel Disease Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Inflammatory Bowel Disease Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Inflammatory Bowel Disease Drugs Sales by Countries (2014-2019) (K Units)
Table Central & South America Inflammatory Bowel Disease Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Inflammatory Bowel Disease Drugs Sales Market Share by Countries
Table Central & South America Inflammatory Bowel Disease Drugs Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Inflammatory Bowel Disease Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Inflammatory Bowel Disease Drugs Revenue Market Share by Countries
Figure Brazil Inflammatory Bowel Disease Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Inflammatory Bowel Disease Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Inflammatory Bowel Disease Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Inflammatory Bowel Disease Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Inflammatory Bowel Disease Drugs Sales by Product (2014-2019) (K Units)
Table Central & South America Inflammatory Bowel Disease Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Inflammatory Bowel Disease Drugs Market Share by Product
Table Central & South America Inflammatory Bowel Disease Drugs Sales by End User (2014-2019) (K Units)
Table Central & South America Inflammatory Bowel Disease Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Inflammatory Bowel Disease Drugs Market Share by End User
Figure Middle East and Africa Inflammatory Bowel Disease Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Inflammatory Bowel Disease Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Inflammatory Bowel Disease Drugs Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Inflammatory Bowel Disease Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Inflammatory Bowel Disease Drugs Sales Market Share by Countries
Table Middle East and Africa Inflammatory Bowel Disease Drugs Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Inflammatory Bowel Disease Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Inflammatory Bowel Disease Drugs Revenue Market Share by Countries
Figure GCC Countries Inflammatory Bowel Disease Drugs Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Inflammatory Bowel Disease Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Inflammatory Bowel Disease Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Inflammatory Bowel Disease Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Inflammatory Bowel Disease Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Inflammatory Bowel Disease Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Inflammatory Bowel Disease Drugs Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Inflammatory Bowel Disease Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Inflammatory Bowel Disease Drugs Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Inflammatory Bowel Disease Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Inflammatory Bowel Disease Drugs Market Share by Product
Table Middle East and Africa Inflammatory Bowel Disease Drugs Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Inflammatory Bowel Disease Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Inflammatory Bowel Disease Drugs Market Share by End User
Table Abbott Laboratories Company Details
Table Abbott Laboratories Inflammatory Bowel Disease Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Abbott Laboratories Recent Development
Table Biocon Ltd Company Details
Table Biocon Ltd Inflammatory Bowel Disease Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Biocon Ltd Recent Development
Table Roche Company Details
Table Roche Inflammatory Bowel Disease Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Roche Recent Development
Table Johnson and Johnson Company Details
Table Johnson and Johnson Inflammatory Bowel Disease Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Johnson and Johnson Recent Development
Table Mylan Pharmaceuticals Company Details
Table Mylan Pharmaceuticals Inflammatory Bowel Disease Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Mylan Pharmaceuticals Recent Development
Table Novartis AG Company Details
Table Novartis AG Inflammatory Bowel Disease Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis AG Recent Development
Table Pfizer Company Details
Table Pfizer Inflammatory Bowel Disease Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table Quest Medical Company Details
Table Quest Medical Inflammatory Bowel Disease Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Quest Medical Recent Development
Table Sanofi Company Details
Table Sanofi Inflammatory Bowel Disease Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Recent Development
Table Takeda Pharmaceutical Company Details
Table Takeda Pharmaceutical Inflammatory Bowel Disease Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Takeda Pharmaceutical Recent Development
Table Global Inflammatory Bowel Disease Drugs Sales Forecast by Regions 2019-2025 (K Units)
Table Global Inflammatory Bowel Disease Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Inflammatory Bowel Disease Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Inflammatory Bowel Disease Drugs Revenue Market Share Forecast by Regions 2019-2025
Table Global Inflammatory Bowel Disease Drugs Sales Forecast by Product 2019-2025 (K Units)
Table Global Inflammatory Bowel Disease Drugs Sales Market Share Forecast by Product 2019-2025
Table Global Inflammatory Bowel Disease Drugs Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Inflammatory Bowel Disease Drugs Revenue Market Share Forecast by Product 2019-2025
Table Global Inflammatory Bowel Disease Drugs Sales Forecast by End User 2019-2025 (K Units)
Table Global Inflammatory Bowel Disease Drugs Sales Market Share Forecast by End User 2019-2025
Figure North America Inflammatory Bowel Disease Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Inflammatory Bowel Disease Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Inflammatory Bowel Disease Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Inflammatory Bowel Disease Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Inflammatory Bowel Disease Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Inflammatory Bowel Disease Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Inflammatory Bowel Disease Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Inflammatory Bowel Disease Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Inflammatory Bowel Disease Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Inflammatory Bowel Disease Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Inflammatory Bowel Disease Drugs Value Chain
Table Inflammatory Bowel Disease Drugs Customers List
Table Inflammatory Bowel Disease Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
炎症性腸疾患の世界市場：市場規模・現状・予測 Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine. Crohn's diseaseand ulcerative colitis are the principal types of inflammatory bowel disease. Crohn's disease affects the small intestine and large intestine, as well as the mouth, esophagus, stom…- 短腸症候群（SBS）治療薬の世界市場：市場規模・現状・予測 Short bowel syndrome (SBS) is a metabolic disorder occurs when the portion of the small intestine is not functioning or removed through surgery due to digestive illness. SBS is caused by lack of function of the small intestine. This results in malabsorption, diarrhea, steatorrhea, fluid and electrol…
- 虚血性心疾患（IHD）医薬品の世界市場：インサイト・予測 Ischemic heart disease (IHD), refers to a group of diseases which includes stable angina, unstable angina, myocardial infarction, and sudden cardiac death. It is within the group of cardiovascular diseases of which it is the most common type. A common symptom is chest pain or discomfort which may tr…
- クラッベ病薬の世界市場：市場規模・現状・予測 Krabbe disease is an uncommon and typically deadly concern of the nervous system. It is an acquired hereditary sickness, which implies that it is passed down in families. Individuals with Krabbe disease are not able to make a sufficient substance called galactosylceramidase, which is expected to mak…
- クラッベ病薬の世界市場：市場規模・現状・予測 Krabbe disease is an uncommon and typically deadly concern of the nervous system. It is an acquired hereditary sickness, which implies that it is passed down in families. Individuals with Krabbe disease are not able to make a sufficient substance called galactosylceramidase, which is expected to mak…